AIMS: Studies of the genetic characteristics of splenic marginal zone lymphoma (SMZL) have failed to identify genetic changes specific to this tumour. Microsatellite instability is a type of genomic instability associated with different types of human cancer. Although microsatellite instability is rare in B cell non-Hodgkin's lymphomas, it has been found in some specific subsets, such as marginal zone lymphomas arising in mucosa associated lymphoid tissue (MALT), where an association with p53 mutation has been described. Because it has been proposed that SMZL and MALT are close in histogenetic terms, this study investigated the comparative frequency of microsatellite instability and p53 mutation in patients with SMZL and MALT lymphomas. METHODS: Microsatellite instability was investigated using seven microsatellite marker loci in 14 patients with SMZL and 20 patients with MALT lymphomas. In an attempt to clarify the role of p53 gene mutation in the pathogenesis of SMZL, exons 5-8 were also investigated by polymerase chain reaction single strand conformation polymorphism (PCR-SSCP) and direct sequencing in a total of 20 patients with SMZL and 22 patients with MALT lymphomas. RESULTS: Microsatellite instability was not detected in patients with SMZL, although five of 20 patients with MALT lymphomas had microsatellite instability. The frequency of p53 mutation was low in both series (two of 20 patients with SMZL and one of 22 patients with MALT lymphomas). No significant association was found between p53 mutation and microsatellite instability. CONCLUSIONS: These results indicate that microsatellite instability is not associated with the molecular pathogenesis of SMZL, confirming the relatively increased frequency of microsatellite instability in MALT lymphomas, and perhaps suggesting that MALT and SMZL have different mechanisms of tumorigenesis.
AIMS: Studies of the genetic characteristics of splenic marginal zone lymphoma (SMZL) have failed to identify genetic changes specific to this tumour. Microsatellite instability is a type of genomic instability associated with different types of humancancer. Although microsatellite instability is rare in B cell non-Hodgkin's lymphomas, it has been found in some specific subsets, such as marginal zone lymphomas arising in mucosa associated lymphoid tissue (MALT), where an association with p53 mutation has been described. Because it has been proposed that SMZL and MALT are close in histogenetic terms, this study investigated the comparative frequency of microsatellite instability and p53 mutation in patients with SMZL and MALT lymphomas. METHODS: Microsatellite instability was investigated using seven microsatellite marker loci in 14 patients with SMZL and 20 patients with MALT lymphomas. In an attempt to clarify the role of p53 gene mutation in the pathogenesis of SMZL, exons 5-8 were also investigated by polymerase chain reaction single strand conformation polymorphism (PCR-SSCP) and direct sequencing in a total of 20 patients with SMZL and 22 patients with MALT lymphomas. RESULTS: Microsatellite instability was not detected in patients with SMZL, although five of 20 patients with MALT lymphomas had microsatellite instability. The frequency of p53 mutation was low in both series (two of 20 patients with SMZL and one of 22 patients with MALT lymphomas). No significant association was found between p53 mutation and microsatellite instability. CONCLUSIONS: These results indicate that microsatellite instability is not associated with the molecular pathogenesis of SMZL, confirming the relatively increased frequency of microsatellite instability in MALT lymphomas, and perhaps suggesting that MALT and SMZL have different mechanisms of tumorigenesis.
Authors: J Dierlamm; L Michaux; I Wlodarska; S Pittaluga; W Zeller; M Stul; A Criel; J Thomas; M Boogaerts; P Delaere; J J Cassiman; C de Wolf-Peeters; C Mecucci; H Van den Berghe Journal: Br J Haematol Date: 1996-04 Impact factor: 6.998
Authors: T A Brentnall; D A Crispin; M P Bronner; S P Cherian; M Hueffed; P S Rabinovitch; C E Rubin; R C Haggitt; C R Boland Journal: Cancer Res Date: 1996-03-15 Impact factor: 12.701
Authors: J Dierlamm; S Pittaluga; I Wlodarska; M Stul; J Thomas; M Boogaerts; L Michaux; A Driessen; C Mecucci; J J Cassiman; C De Wolf-Peeters; H Van den Berghe Journal: Blood Date: 1996-01-01 Impact factor: 22.113
Authors: G Volpe; B Gamberi; C Pastore; A Roetto; M Pautasso; G Parvis; C Camaschella; U Mazza; G Saglio; G Gaidano Journal: Ann Hematol Date: 1996-02 Impact factor: 3.673
Authors: J Randerson; L Cawkwell; A Jack; J A Child; F Lewis; N Hall; P Johnson; P Evans; S Barrans; G J Morgan Journal: Br J Haematol Date: 1996-04 Impact factor: 6.998
Authors: M Sánchez-Beato; A I Sáez; I C Navas; P Algara; M Sol Mateo; R Villuendas; F Camacho; A Sánchez-Aguilera; E Sánchez; M A Piris Journal: Am J Pathol Date: 2001-07 Impact factor: 4.307